Quality-aware multimodal inference
The system direction combines synchronized multimodal signals with explicit signal-quality information so inference can adapt when one modality is degraded or unavailable.
Neurotechnology · invention · patent pending
NDMS — Neuro Dynamic Masking System
NDMS is a privacy-aware multimodal neurotechnology programme focused on structured multimodal signal integration, quality-aware inference, edge-oriented processing, and interpretable system design.
The project sits between neurotechnology, multimodal machine learning, and responsible system design. Its public presentation is deliberately bounded: NDMS is an invention and technology-development programme, not a validated diagnostic or clinical product.
PCT/IB2025/060348Patent pendingPrivacy-awareMultimodal AI
System principles
What the public concept emphasizes
Edge-oriented privacy
The invention programme emphasizes local or edge-oriented processing and consent-aware system design rather than treating raw multimodal data as an unconstrained cloud resource.
Interpretability and responsible use
Outputs are framed as calibrated system estimates with explicit limitations. The project is not presented as a validated diagnostic, clinical, hiring, or surveillance product.
Public architecture schematic
From synchronized signals to a quality-aware continuous estimate
This schematic shows the public system logic at a deliberately high level. It communicates the engineering structure without turning the portfolio into a disclosure of unpublished implementation details or claim drafting.
01
Synchronized inputs
Audio and visual streams enter a time-aligned processing path.
02
Windowed features
Features are extracted over consecutive analysis windows rather than treated as one undifferentiated recording.
03
Signal quality
Per-modality quality information is estimated alongside the behavioural features.
04
Quality-conditioned gating
The inference path can favor multimodal or single-modality processing when signal quality changes.
05
Continuous estimate
The system produces a continuous masking-probability estimate rather than a categorical diagnostic label.
Edge-oriented executionQuality-aware routingMultimodal / single-modality fallbackContinuous output
Claim boundary
Technology development is not clinical validation
Patent status, prototype development, and system architecture do not establish clinical validity. The site therefore separates invention claims from evidence claims and avoids describing NDMS as a diagnostic, therapeutic, or clinically validated product.
Responsible-use boundary
The public positioning does not frame NDMS as a hiring, surveillance, or coercive decision system. The emphasis is consent-aware, privacy-conscious technology development with calibrated outputs and explicit limitations.